Encontrados 5 documentos, a visualizar página 1 de 1
Disparities in the organisation of national healthcare systems for treatment of...
Michelsen, Brigitte; Østergaard, Mikkel; Nissen, Michael John; Ciurea, Adrian; Möller, Burkhard; Midtbøll Ørnbjerg, Lykke; Horák, PavelFunding Information: The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG. Novartis had no influence on the data collection, analyses, manuscript preparation or decision to submit the manuscript. Publisher Copyright: © 2025; Background: Studies on national policies for biologics are warranted. Objectives: To map and compare national healthcare set-ups for prescription, star...
Differences in the response to TNF inhibitors at distinct joint locations in pa...
Ciurea, Adrian; Kissling, Seraphina; Götschi, Andrea; Ørnbjerg, Lykke Midtbøll; Rasmussen, Simon Horskjær; Tamási, Bálint; Möller, BurkhardPublisher Copyright: © The Author(s) 2025.; Background: Efficacy of tumour necrosis factor inhibitors (TNFi) for peripheral arthritis in patients with psoriatic arthritis (PsA) has been established in randomized clinical trials that have used improvement in summated joint counts as an outcome. Whether joints at different anatomical locations might respond differentially to TNFi remains unknown. The aim of the s...
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis
Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Linde, Louise; Jacobsson, Lennart; Nissen, Michael J.; Kristianslund, Eirik Klami; Santos, Maria JoséFunding Information: This work was supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. Publisher Copyright: © 2024 The Authors; Objective: To investigate real-world retention and remission rates in PsA patients initiating a 2nd or 3rd TNFi and the association with reason for discontinuation from the previous TNFi-treatment....
Recording of non-musculoskeletal manifestations, comorbidities and safety outco...
Ahmadzay, Zohra F.; Heberg, Jette; Jørgensen, Jacob B.; Ørnbjerg, Lykke M.; Østergaard, Mikkel; Møller-Bisgaard, Signe; Michelsen, BrigitteFunding Information: This work was supported by Novartis Pharma AG. EuroSpA was financially supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit the manuscript. Publisher Copyright: © 2024 The Author(s).; Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who h...
Differences and similarities between the EULAR/ASAS-EULAR and national recommen...
Michelsen, Brigitte; Østergaard, Mikkel; Nissen, Michael John; Ciurea, Adrian; Möller, Burkhard; Ørnbjerg, Lykke Midtbøll; Zavada, JakubFunding Information: The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG . Novartis had no influence on the data collection, analyses, manuscript preparation or decision to submit the manuscript. Publisher Copyright: © 2023 The Author(s); This is the first report comparing EULAR and national treatment recommendations for PsA patients across Europe, and the first this decad...